Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
ASMF 
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
ASMF
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Neuland Laboratories- A dedicated 100% API provider.
EU-WC
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
About the Company : Farmak, A.S. is a privately held chemical and pharmaceutical company based in the Czech Republic. It specializes in researching, developing and producing active pharmaceutical ingr...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
About the Company : Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling ...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
Neuland Laboratories- A dedicated 100% API provider.
About the Company : Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the p...
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
About the Company : Kinsy, an independent CDMO in Spain, offers over 30 years of expertise in developing and manufacturing advanced pharmaceutical intermediates and APIs. We provide innovative route d...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Moxonidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moxonidine, including repackagers and relabelers. The FDA regulates Moxonidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moxonidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Moxonidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Moxonidine supplier is an individual or a company that provides Moxonidine active pharmaceutical ingredient (API) or Moxonidine finished formulations upon request. The Moxonidine suppliers may include Moxonidine API manufacturers, exporters, distributors and traders.
click here to find a list of Moxonidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Moxonidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Moxonidine active pharmaceutical ingredient (API) in detail. Different forms of Moxonidine DMFs exist exist since differing nations have different regulations, such as Moxonidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Moxonidine DMF submitted to regulatory agencies in the US is known as a USDMF. Moxonidine USDMF includes data on Moxonidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Moxonidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Moxonidine suppliers with USDMF on PharmaCompass.
A Moxonidine CEP of the European Pharmacopoeia monograph is often referred to as a Moxonidine Certificate of Suitability (COS). The purpose of a Moxonidine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Moxonidine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Moxonidine to their clients by showing that a Moxonidine CEP has been issued for it. The manufacturer submits a Moxonidine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Moxonidine CEP holder for the record. Additionally, the data presented in the Moxonidine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Moxonidine DMF.
A Moxonidine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Moxonidine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Moxonidine suppliers with CEP (COS) on PharmaCompass.
A Moxonidine written confirmation (Moxonidine WC) is an official document issued by a regulatory agency to a Moxonidine manufacturer, verifying that the manufacturing facility of a Moxonidine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Moxonidine APIs or Moxonidine finished pharmaceutical products to another nation, regulatory agencies frequently require a Moxonidine WC (written confirmation) as part of the regulatory process.
click here to find a list of Moxonidine suppliers with Written Confirmation (WC) on PharmaCompass.
Moxonidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Moxonidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Moxonidine GMP manufacturer or Moxonidine GMP API supplier for your needs.
A Moxonidine CoA (Certificate of Analysis) is a formal document that attests to Moxonidine's compliance with Moxonidine specifications and serves as a tool for batch-level quality control.
Moxonidine CoA mostly includes findings from lab analyses of a specific batch. For each Moxonidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Moxonidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Moxonidine EP), Moxonidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Moxonidine USP).
LOOKING FOR A SUPPLIER?
